Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
glycopyrronium tosylate bulk supplier for pharma manufacturers

Glycopyrronium Tosylate 2.4% Suppliers & Bulk Manufacturers

Available Forms:

Available Strengths: 2.4%

Reference Brands: Qbrexza (USA)

Category: Derma Drugs

Glycopyrronium Tosylate is a Derma Drugs product available as in strengths 2.4%. It corresponds to the reference brand Qbrexza (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Glycopyrronium tosylate, marketed under the brand name Qbrexza in the United States, is a topical anticholinergic medication indicated for the treatment of primary axillary hyperhidrosis. Primary axillary hyperhidrosis is a chronic condition characterized by excessive underarm sweating that is not related to heat or physical activity and can significantly affect daily life and social interactions.

Glycopyrronium tosylate works by blocking muscarinic acetylcholine receptors in the sweat glands, thereby reducing the stimulation responsible for excessive sweat production. It is formulated as a pre-moistened, single-use topical cloth that allows localized application directly to the affected area. This targeted delivery helps minimize systemic absorption while providing effective control of sweating.

The medication is approved for use in both adult and pediatric patients within the indicated age range, offering a non-invasive alternative to oral anticholinergic therapies or injectable treatments. Glycopyrronium tosylate is generally applied once daily and is designed for convenient, at-home use. Its topical formulation makes it a preferred option for patients seeking effective management of axillary hyperhidrosis with a reduced risk of widespread anticholinergic side effects.

Glycopyrronium Tosylate — third party manufacturing & bulk supply

Glycopyrronium Tosylate 2.4% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Glycopyrronium Tosylate is a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glycopyrronium Tosylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Glycopyrronium Tosylate →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Glycopyrronium tosylate is used for the treatment of primary axillary hyperhidrosis, a condition characterized by excessive underarm sweating in adults and pediatric patients of approved age.

Glycopyrronium tosylate is a synthetic anticholinergic compound derived from glycopyrronium, formulated as a tosylate salt to enhance stability and suitability for topical use.

The trade name of glycopyrronium tosylate is Qbrexza.

Qbrexza is manufactured and marketed by Journey Medical Corporation in the United States.

The complete generic name is glycopyrronium tosylate.

The brand name is Qbrexza.

Glycopyrronium tosylate finished dosage form for Qbrexza is manufactured in facilities approved for pharmaceutical production for the U.S. market, with manufacturing locations disclosed by the marketing authorization holder in regulatory filings.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Prednicarbate

Strength:
(0.1%

Form: topical cream, ointment

Reference Brands: Dermatop (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.